![Michael J. Walsh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael J. Walsh
Plus aucun poste en cours
Profil
Mr. Michael J.
Walsh is a President, Secretary, Director and CFO at Evida Biosciences, Inc. He is on the Board of Directors at Kanisa Pharmaceuticals, Inc. and Evida Biosciences, Inc. Mr. Walsh was previously employed as a Chief Commercial Officer & EVP by Cypress Bioscience, Inc., a Chairman & Chief Executive Officer by Proprius Pharmaceuticals, Inc., an Executive Chairman by Prometheus Laboratories, Inc., a Manager-Therapeutic Operations by La Jolla Pharmaceutical Co., a Chairman by Oculir, Inc., a Director-Worldwide Marketing & European Operations by Quidel Corp., and a Partner by Windamere Venture Partners LLC.
He also served on the board at Exagen, Inc. He received his undergraduate degree from the University of Notre Dame and an MBA from Pepperdine University.
Postes actifs de Michael J. Walsh
| Sociétés | Poste | Début |
|---|---|---|
Kanisa Pharmaceuticals, Inc.
 Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and provides medical services | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael J. Walsh
| Sociétés | Poste | Fin |
|---|---|---|
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Corporate Officer/Principal | 04/03/2010 |
Oculir, Inc.
 Oculir, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Président | 23/10/2008 |
Windamere Venture Partners LLC
 Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners invests in seed and early-stage companies. The firm target companies are product-focused healthcare companies in the areas of emerging pharmaceuticals, specialty pharmaceuticals and medical devices. | Analyste en capital-investissement | 31/12/2007 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Fondateur | 01/01/2004 |
| EXAGEN INC. | Directeur/Membre du Conseil | - |
Formation de Michael J. Walsh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Provides diagnostic healthcare solutions | Health Technology |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Health Technology |
Kanisa Pharmaceuticals, Inc.
Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and provides medical services | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculir, Inc.
Oculir, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
Proprius Pharmaceuticals, Inc.
 Proprius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, commercializes and markets pharmaceutical products | Health Technology |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Exagen, Inc.
 Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
Windamere Venture Partners LLC
Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners invests in seed and early-stage companies. The firm target companies are product-focused healthcare companies in the areas of emerging pharmaceuticals, specialty pharmaceuticals and medical devices. | Finance |
